Prellis Biologics

Berkeley, United States

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

Mar 2025

Series C

3D Printing Biopharma Biotechnology Therapeutics

Top Investors

Plug and PlayKhosla VenturesTrue VenturesCivilization VenturesCantos

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Prellis Biologics

Who are Prellis Biologics's investors?

Prellis Biologics's investors include Plug and Play, Khosla Ventures, True Ventures, Civilization Ventures, Cantos.

Where is Prellis Biologics headquartered?

Prellis Biologics is headquartered in Berkeley, United States.

What does Prellis Biologics do?

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

What stage is Prellis Biologics at?

Prellis Biologics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2025.

MLA

"Prellis Biologics — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/prellis-biologics. Accessed July 1, 2026.

APA

VCBacked. (2025). Prellis Biologics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/prellis-biologics

Wikipedia (cite web)

{{cite web |title=Prellis Biologics — Funding & Investors |url=https://www.vcbacked.co/company/prellis-biologics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2025.

Similar Companies in 3D Printing